Showing results (81-90 of 178) with videos related to
Sort By:
Pageof 18
Blood|May 16, 2022
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell diseaseJulia Z Xu, Anna Conrey, Ingrid Frey, et al.Journal of Pediatric Hematology/Oncology|September 24, 2011
Changing pattern of hospital admissions of children with sickle cell disease over the last 50 yearsThomas G Day, Swee Lay Thein, Emma Drasar, et al.Pediatric Pulmonology|December 24, 2015
Longitudinal assessment of lung function in children with sickle cell diseaseAlan Lunt, Emily McGhee, Karl Sylvester, et al.Analytical Biochemistry|October 28, 2008
Quantitation of hepcidin in human urine by liquid chromatography-mass spectrometrySukhvinder S Bansal, John M Halket, Adrian Bomford, et al.Rapid Communications in Mass Spectrometry : RCM|April 15, 2010
Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometerSukhvinder S Bansal, Vincenzo Abbate, Adrian Bomford, et al.Scientific Reports|August 28, 2020
Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell diseaseMichael Brad Strader, Sirsendu Jana, Fantao Meng, et al.Blood|June 17, 2009
The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cellsKarin Wahlberg, Jie Jiang, Helen Rooks, et al.Hematology/Oncology Clinics of North America|November 18, 2022
Clinical Vignettes Part IJason A Levy, Arthur L Burnett, Caterina P Minniti, et al.The Journal of Pediatrics|July 25, 2006
Impact of acute chest syndrome on lung function of children with sickle cell diseaseKarl P Sylvester, Richard A Patey, Peter Milligan, et al.American Journal of Hematology|July 11, 2008
Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemiaPinar Ulug, Nisha Vasavda, Rohan Kumar, et al.Pageof 18